Risk of hepatitis B reactivation and cytomegalovirus related infections with Mogamulizumab: A retrospective study of international pharmacovigilance database by Shuai Wang, Apoorva Jayarangaiah, Mariuxi Malone, Tarek Elrafei, Lewis Steinberg, Abhishek Kumar

Get full text